|

Standard Reagents, Pancreatic Cancer Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Ruijin Hospital1

Indications

  • Borderline Resectable Pancreatic Adenocarcinoma1
  • Resectable Pancreatic Adenocarcinoma1
  • Cancer1

Other1 trial

A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.